Drugs / Vizol S DIGI EYE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07050446 | Mar → Aug 2024 | dry eye syndrome | Jadran Galenski laboratorij d.d. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vizol S DIGI EYE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07050446 ↗ |
| Route | Topical | “topical administration of 1 drop of Vizol S DIGI EYE in each eye 4 times a day for 28 days” NCT07050446 ↗ |